183 related articles for article (PubMed ID: 8248552)
1. HDR versus LDR gynecological brachytherapy revisited.
Scalliet P; Gerbaulet A; Dubray B
Radiother Oncol; 1993 Aug; 28(2):118-26. PubMed ID: 8248552
[TBL] [Abstract][Full Text] [Related]
2. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
3. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
4. [The radiobiology of gynecologic HDR and LDR afterloading technics].
Bauer M; Schulz-Wendtland R
Rontgenblatter; 1989 Jan; 42(1):54-6. PubMed ID: 2645638
[TBL] [Abstract][Full Text] [Related]
5. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
6. Constraints in the use of repair half times and mathematical modelling for the clinical application of HDR and PDR treatment schedules as an alternative for LDR brachytherapy.
Pop LA; van den Broek JF; Visser AG; van der Kogel AJ
Radiother Oncol; 1996 Feb; 38(2):153-62. PubMed ID: 8966228
[TBL] [Abstract][Full Text] [Related]
7. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
8. High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations.
Stitt JA; Fowler JF; Thomadsen BR; Buchler DA; Paliwal BP; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1992; 24(2):335-48. PubMed ID: 1526873
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
10. High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.
Ling CC; Sahoo N; Leibel S; Anderson LL
Radiother Oncol; 1992 Oct; 25(2):103-10. PubMed ID: 1438929
[TBL] [Abstract][Full Text] [Related]
11. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
[TBL] [Abstract][Full Text] [Related]
12. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma.
Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728
[TBL] [Abstract][Full Text] [Related]
13. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study.
Petera J; Matula P; Paluska P; Sirak I; Macingova Z; Kasaova L; Frgala T; Hodek M; Vosmik M
Neoplasma; 2009; 56(2):163-8. PubMed ID: 19239332
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric and radiobiological comparison of volumetric modulated arc therapy, high-dose rate brachytherapy, and low-dose rate permanent seeds implant for localized prostate cancer.
Yang R; Zhao N; Liao A; Wang H; Qu A
Med Dosim; 2016; 41(3):236-41. PubMed ID: 27400663
[TBL] [Abstract][Full Text] [Related]
15. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Nucletron and ROCS brachytherapy treatment planning systems for LDR and HDR applications.
Ho AK; Sibata CH; Shin KH
Med Dosim; 1994; 19(3):147-9. PubMed ID: 7818754
[TBL] [Abstract][Full Text] [Related]
17. [Gynecologic brachytherapy--from low-dose-rate to high-tech].
Herrmann T; Christen N; Alheit HD
Strahlenther Onkol; 1993 Mar; 169(3):141-51. PubMed ID: 8465248
[TBL] [Abstract][Full Text] [Related]
18. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
19. High dose rate versus low dose rate brachytherapy for squamous cell carcinoma of the cervix: an economic analysis.
Jones G; Lukka H; O'Brien B
Br J Radiol; 1994 Nov; 67(803):1113-20. PubMed ID: 7820405
[TBL] [Abstract][Full Text] [Related]
20. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
